Drawing for PERBIO SCIENCE

USPTO serial 75842547

PERBIO SCIENCE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MCMORROW, RONALD G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PERBIO SCIENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Francis J. Duffin

FRANCIS J DUFFIN WIGGIN & DANAONE CENTURY TWRNEW HAVEN, CT 06508-1832UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Laboratory, biotechnology, bioresearch, clinical and in vitro diagnostic chemicals and reagents, and diagnostic test kits consisting of such chemicals and reagents and other components thereof; immunoassay test kits for measuring or detecting immune system related molecules in biological fluids; chemical preparations, namely, immobilized substances for purification of chemical and biological materials for use in research and in the chemical and biotechnology industries; chemicals for industrial use, namely, chemical preparations for use in the manufacture of analytical and biotechnical applications; chemicals for scientific use, namely, chemicals for use in analytical and biotechnical applications; diagnostic reagents for scientific useACTIVE—
005Sera media for cell cultivation and nutrition, tissue culture sera and media for in vitro medical diagnostic use; diagnostics for medical purposes, namely, in-vitro diagnostics; in vitro diagnostic assay kits including antibodies, antigens, control reagents, calibrating reagents and test reagents; media for separating populations of cells and growth thereof in a cell culture, the media comprising animal sera, growth factors, extracellular matrix components, media and/or immunochemical reagents comprising antibodies and complements; control solutions for medical purposesACTIVE—
009Instruments and devices for laboratory, biotechnology, bioresearch, and clinical search and/or analysis, namely, instruments and apparatus for detection, assaying, synthesis and analysis of biomolecules, purification and characterization of proteins, study and development of drugs that act on the immune system, high throughput screening, gas chromatography; dialysis apparatus used to separate substances for use in research and development in the chemical and biotechnological industries; apparatus for use in scientific laboratories in connection with the handling of chemical preparations and samples - namely, vials, caps and seals for vials, flasks, vacuum tubes, pipettes, capillary tubes, syringes, reagent dispensers, electric unit for heating/stirring of samples, electric evaporator/concentrators for concentrating reaction media, isolating residues and solutions and separating, detecting, analyzing, monitoring and/or measuring materials in fluid and/or solid samples, and parts therefor; data collecting, analyzing, computing and/or calculating apparatus and systems, and parts therefor; fluid pumping apparatus and fluid injection apparatus for scientific purposes, such as pumps and injection valves used in chromatographic analysis, pipettors/diluters for the preparation of samples in clinical, industrial, bioresearch and biotechnology laboratories, and various pumps and probes used in automatic clinical analyzers and biochemical and chemical analyzers and synthesizers, and parts therefor; fluid control apparatus for producing biochemicals and reagents, and parts therefor; apparatus and parts therefor used to separate solutions for chemical and biochemical research in the chemical and biochemical industries, namely, chromatography columnsACTIVE—
010Medical devices, namely surgical implants, ear, nose and throat implants, medical devices for treating penile and erectile dysfunction and medical devices for treating menorrhagia, namely, apparatus and instruments for stanching vascular leakage, apparatus and instruments for heat induced and/or pressurized stanching of vascular leakage, apparatus and instruments for heat and/or pressurized treatment of mammalian tissue, apparatus and instruments for stanching of uterine bleeding including abnormal menstrual bleeding, and apparatus and instruments for heat induced and/or pressurized stanching of uterus bleeding including abnormal menstrual bleeding; containers for sterile liquid management, and single-use plastic bags designed to transport and store sterile liquids; voice prosthesis; artificial limbs, eyes and teethACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 8, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 16, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 22, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 2, 2002NPUBNOTICE OF PUBLICATION—
Oct 25, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 17, 2001CNEAEXAMINERS AMENDMENT MAILED—
May 1, 2001CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 22, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 22, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 1999DOCKASSIGNED TO EXAMINER—
Dec 13, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance